Stay updated with breaking news from Hematologic Malignancies Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Indiana University School of Medicine scientists are on a mission to understand why hematopoietic stem cells, responsible for producing all types of mature bloo
Unprecedented shortages of key cancer drugs in the United States could disrupt treatment for tens of thousands of patients with various forms of the disease in the coming months unless hospitals take action, experts say.
For the 11th consecutive year, OncLive is honored to recognize oncology leaders whose innovations have contributed to immeasurable improvements in outcomes for countless patients.
/PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today...
10.08.2022 - Phase 1 umbrella trial for hematologic malignancies open for enrollment Publication in Cell further validates use of foundational technology to identify novel tumor antigens and effective TCRs TSC-200-A2 (HPV) and TSC-204-C7 (MAGE-A1) IND filings ...